Ideal cardiovascular health influences cardiovascular disease risk associated with high lipoprotein(a) levels and genotype: The EPIC-Norfolk prospective population study

被引:59
|
作者
Perrot, Nicolas [1 ,2 ]
Verbeek, Rutger [3 ]
Sandhu, Manjinder [4 ,5 ]
Boekholdt, S. Matthijs [6 ]
Hovingh, G. Kees [3 ]
Wareham, Nicholas J. [7 ]
Khaw, Kay-Tee [4 ]
Arsenault, Benoit J. [1 ,2 ]
机构
[1] Inst Univ Cardiol & Pneumol Quebec, Ctr Rech, Y-2110,Pavillon Marguerite DYouville,2725 Chemin, Ste Foy, PQ G1V 4G5, Canada
[2] Univ Laval, Fac Med, Dept Med, Quebec City, PQ, Canada
[3] Acad Med Ctr, Dept Vasc Med, Amsterdam, Netherlands
[4] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB2 1TN, England
[5] Wellcome Trust Sanger Inst, Genet Epidemiol Grp, Hinxton, England
[6] Acad Med Ctr, Dept Cardiol, Amsterdam, Netherlands
[7] MRC Epidemiol Unit, Cambridge, England
基金
英国医学研究理事会;
关键词
Lipoprotein(a); Lifestyle; Genetics; Ideal cardiovascular health; Cardiovascular diseases; LOW-DENSITY-LIPOPROTEIN; CORONARY-HEART-DISEASE; AORTIC-VALVE STENOSIS; OXIDIZED PHOSPHOLIPIDS; MYOCARDIAL-INFARCTION; PHYSICAL-ACTIVITY; ARTERY-DISEASE; STATIN THERAPY; COHORT; TRIAL;
D O I
10.1016/j.atherosclerosis.2016.11.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aims: Lipoprotein(a) (Lp[a]) is a strong genetic risk factor for cardiovascular disease (CVD). The American Heart Association has prioritised seven cardiovascular health metrics to reduce the burden of CVD: body mass index, healthy diet, physical activity, smoking status, blood pressure, diabetes and cholesterol levels (together also known as ideal cardiovascular health). Our objective was to determine if individuals with high Lp(a) levels could derive cardiovascular benefits if characterized by ideal cardiovascular health. Methods: A total of 14,051 participants of the EPIC-Norfolk study were stratified according to the cardiovascular health score (based on the number of health metrics with an ideal, intermediate or poor status). Of them, 1732 had a CVD event during a mean follow-up of 11.5 years. Cox proportional hazards models were used to describe the association between the cardiovascular health score and Lp(a) level or genotype (as estimated by the rs10455872 variant) with the risk of CVD. Results: We observed little or no differences in serum Lp(a) levels across the seven cardiovascular health metric categories. Among participants with high serum Lp(a) levels >50 mg/dl), those in the highest (i.e. healthiest) cardiovascular health score category (10-14) had an adjusted hazard ratio for cardiovascular disease of 0.33 (95% CI = 0.17-0.63, p = 0.001) compared to participants in the lowest (i.e. unhealthiest) cardiovascular health score category(0-4). Similar results were obtained when we replaced Lp(a) with rs10455872. Conclusions: Although Lp(a) levels are only slightly influenced by cardiovascular health metrics, an ideal cardiovascular health could substantially reduce CVD risk associated with high Lp(a) levels or genotype. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:47 / 52
页数:6
相关论文
共 50 条
  • [1] Ideal cardiovascular health and risk of cardiovascular events in the EPIC-Norfolk prospective population study
    Lachman, Sangeeta
    Peters, Ron J. G.
    Lentjes, Marleen A. H.
    Mulligan, Angela A.
    Luben, Robert N.
    Wareham, Nicholas J.
    Khaw, Kay-Tee
    Boekholdt, S. Matthijs
    [J]. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2016, 23 (09) : 986 - 994
  • [2] Tryptophan metabolites and incident cardiovascular disease: The EPIC-Norfolk prospective population study
    Teunis, Charlotte J.
    Stroes, Erik S. G.
    Boekholdt, S. Matthijs
    Wareham, Nicholas J.
    Murphy, Andrew J.
    Nieuwdorp, Max
    Hazen, Stanley L.
    Hanssen, Nordin M. J.
    [J]. ATHEROSCLEROSIS, 2023, 387
  • [3] TRYPTOPHAN METABOLITES AND INCIDENT CARDIOVASCULAR DISEASE IN THE EPIC-NORFOLK PROSPECTIVE POPULATION STUDY
    Teunis, C.
    Stroes, E.
    Boekholdt, M.
    Wareham, N.
    Murphy, A.
    Nieuwdorp, M.
    Hazen, S.
    Hanssen, N.
    [J]. ATHEROSCLEROSIS, 2023, 379
  • [4] Initial thyroid status and cardiovascular risk factors: The EPIC-Norfolk prospective population study
    Boekholdt, S. Matthijs
    Titan, Silvia M.
    Wiersinga, Wilmar M.
    Chatterjee, Krishna
    Basart, Dick C. G.
    Luben, Robert
    Wareham, Nicholas J.
    Khaw, Kay-Tee
    [J]. CLINICAL ENDOCRINOLOGY, 2010, 72 (03) : 404 - 410
  • [5] Lipoprotein(a) and Risk of Coronary, Cerebrovascular, and Peripheral Artery Disease The EPIC-Norfolk Prospective Population Study
    Gurdasani, Deepti
    Sjouke, Barbara
    Tsimikas, Sotirios
    Hovingh, G. Kees
    Luben, Robert N.
    Wainwright, Nicholas W. J.
    Pomilla, Cristina
    Wareham, Nicholas J.
    Khaw, Kay-Tee
    Boekholdt, S. Matthijs
    Sandhu, Manjinder S.
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2012, 32 (12) : 3058 - 3065
  • [6] Microalbuminuria, cardiovascular risk factors and cardiovascular morbidity in a British population: The EPIC-Norfolk population-based study
    Yuyun, MF
    Khaw, KT
    Luben, R
    Welch, A
    Bingham, S
    Day, NE
    Wareham, NJ
    [J]. EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2004, 11 (03): : 207 - 213
  • [7] LIPOPROTEIN(A) IMPROVES CARDIOVASCULAR RISK PREDICTION BASED ON THE ACC/AHA AND SCORE ALGORITHMS IN INTERMEDIATE RISK PATIENTS; THE EPIC-NORFOLK PROSPECTIVE POPULATION STUDY
    Verbeek, Rutger
    Sandhu, Manjinder
    Hovingh, G. Kees
    Sjouke, Barbara
    Wareham, Nicholas
    Zwinderman, Aeilko
    Kastelein, John
    Khaw, Kay-Tee
    Tsimikas, Sotirios
    Boekholdt, S. Matthijs
    [J]. ATHEROSCLEROSIS, 2017, 263 : E27 - E28
  • [8] Serious underestimation of the overall risk of cardiovascular events if extrapolated from cardiovascular mortality: observations from the EPIC-Norfolk prospective population study
    Jorstad, H. T.
    Colkesen, B. E.
    Boekholdt, S. M.
    Tijssen, J. G. P.
    Wareham, N. J.
    Khaw, K. T.
    Peters, R. J. G.
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 : 17 - 17
  • [9] POPULATION AND ASSAY THRESHOLDS FOR THE PREDICTIVE VALUE OF LIPOPROTEIN(A) FOR RISK OF CORONARY ARTERY DISEASE: THE EPIC-NORFOLK PROSPECTIVE POPULATION STUDY
    Verbeek, R.
    Boekholdt, S. M.
    Stoekenbroek, R. M.
    Hovingh, G. K.
    Witztum, J. L.
    Wareham, N. J.
    Sandhu, M. S.
    Khaw, K. T.
    Tsimikas, S.
    [J]. ATHEROSCLEROSIS, 2016, 252 : E127 - E127
  • [10] Cardiovascular risk factors associated with polymyalgia rheumatica and giant cell arteritis in a prospective cohort: EPIC-Norfolk Study
    Yates, Max
    Luben, Robert
    Hayat, Shabina
    Mackie, Sarah L.
    Watts, Richard A.
    Khaw, Kay-Tee
    Wareham, Nick J.
    MacGregor, Alex J.
    [J]. RHEUMATOLOGY, 2020, 59 (02) : 319 - 323